Burkhart Schraven

What is he best known for?

The fields of study he is best known for:

• Gene
• Enzyme
• Immune system

The scientist’s investigation covers issues in Cell biology, Signal transducing adaptor protein, T-cell receptor, Signal transduction and Molecular biology. He studies Phosphorylation, a branch of Cell biology. His Signal transducing adaptor protein research is multidisciplinary, incorporating perspectives in Intracellular signalling, Signalling and Transmembrane protein.

His biological study spans a wide range of topics, including Receptor, Adaptor Signaling Protein, B-cell receptor and Metabolism. His work on Rap1 and Small GTPase as part of his general Signal transduction study is frequently connected to Membrane protein, thereby bridging the divide between different branches of science. His research investigates the connection between Molecular biology and topics such as CD3 that intersect with issues in Monoclonal antibody, Cell surface receptor and T lymphocyte.

His most cited work include:

• Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment (362 citations)
• A Logical Model Provides Insights into T Cell Receptor Signaling (277 citations)
• Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling. (193 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Cell biology, T cell, T-cell receptor, Signal transducing adaptor protein and Signal transduction. His Cell biology research integrates issues from Integrin, Immune system and Transmembrane protein. His T cell research is multidisciplinary, incorporating elements of Molecular biology and CD3.

His T-cell receptor research incorporates elements of Receptor, Cancer research, Apoptosis and MAPK/ERK pathway. His research investigates the connection between Signal transducing adaptor protein and topics such as Cell activation that intersect with problems in Linker for Activation of T cells. His work in Phosphorylation tackles topics such as Tyrosine kinase which are related to areas like Tyrosine.

He most often published in these fields:

• Cell biology (62.72%)
• T cell (31.36%)
• T-cell receptor (24.85%)

What were the highlights of his more recent work (between 2013-2021)?

• Cell biology (62.72%)
• T cell (31.36%)
• Immune system (18.34%)

In recent papers he was focusing on the following fields of study:

Cell biology, T cell, Immune system, Immunology and T-cell receptor are his primary areas of study. His studies deal with areas such as Jurkat cells and Integrin as well as Cell biology. His T cell research incorporates themes from Molecular biology, Apoptosis and Proto-oncogene tyrosine-protein kinase Src.

Burkhart Schraven combines subjects such as Excitotoxicity, Cell and Cytokine with his study of Immune system. His work carried out in the field of T-cell receptor brings together such families of science as Reactive oxygen species and Cytokine secretion. His Signal transduction research is multidisciplinary, incorporating elements of Experimental autoimmune encephalomyelitis and Antigen.

Between 2013 and 2021, his most popular works were:

• Very-late-antigen-4 (VLA-4)-mediated brain invasion by neutrophils leads to interactions with microglia, increased ischemic injury and impaired behavior in experimental stroke. (117 citations)
• Catchup: a mouse model for imaging-based tracking and modulation of neutrophil granulocytes. (115 citations)
• T cells and reactive oxygen species (111 citations)

In his most recent research, the most cited papers focused on:

• Gene
• Enzyme
• Immune system

His primary scientific interests are in Cell biology, Immune system, T cell, Acquired immune system and T-cell receptor. His specific area of interest is Cell biology, where Burkhart Schraven studies Cell adhesion molecule. The various areas that Burkhart Schraven examines in his Immune system study include Cell, Infiltration, Pathology, Microglia and Receptor.

His studies in T cell integrate themes in fields like Methylglyoxal, Cell growth, Tyrosine kinase, CD8 and Immunotherapy. His Tyrosine kinase study combines topics from a wide range of disciplines, such as CD28, Jurkat cells, ZAP70 and Phosphorylation. The study incorporates disciplines such as Apoptosis and Signal transduction in addition to T-cell receptor.